Jinhong Chang Selected Research

Porcine Reproductive and Respiratory Syndrome (PRRS)

1/2022	Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
7/2014	An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses.
1/2012	RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response.
1/2009	Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinhong Chang Research Topics

Disease

41	Infections 12/2023 - 04/2007
17	Chronic Hepatitis B 12/2023 - 09/2010
15	Virus Diseases (Viral Diseases) 01/2022 - 05/2007
10	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2008
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022 - 01/2009
4	Hepatitis B 10/2020 - 12/2012
4	Bites and Stings (Sting) 12/2019 - 02/2015
4	Dengue (Dengue Fever) 01/2018 - 02/2012
3	Yellow Fever 10/2020 - 12/2016
3	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2018 - 06/2013
3	Fever (Fevers) 01/2018 - 06/2013
2	Disease Progression 12/2021 - 08/2014
2	Diarrhea 04/2013 - 04/2009
2	Viremia 11/2011 - 01/2011
1	COVID-19 01/2022
1	Coronavirus Infections 01/2022
1	Flavivirus Infections 01/2022
1	Leukemia 01/2020
1	Neoplasms (Cancer) 12/2019
1	Carcinogenesis 10/2019
1	Lassa Fever (Fever, Lassa) 01/2019
1	Craniosynostoses (Craniosynostosis) 12/2018
1	Acrocephalosyndactylia (Apert Syndrome) 12/2018
1	Ebola Hemorrhagic Fever 01/2018
1	Japanese Encephalitis 01/2018
1	Marburg Virus Disease 02/2017
1	Body Weight (Weight, Body) 12/2016
1	Disease Susceptibility (Diathesis) 01/2015
1	Persistent Infection 08/2014
1	Common Cold 05/2014
1	Fibrosis (Cirrhosis) 06/2013
1	Inflammation (Inflammations) 01/2012
1	Chronic Hepatitis C 03/2011

Drug/Important Bio-Agent (IBA)

38	Antiviral Agents (Antivirals)IBA 12/2023 - 02/2008
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2007
12	CytokinesIBA 01/2022 - 01/2009
9	InterferonsIBA 01/2022 - 08/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2014
7	Pattern Recognition ReceptorsIBA 01/2022 - 01/2009
6	Viral DNAIBA 12/2023 - 06/2013
6	GlucosidasesIBA 01/2018 - 01/2011
5	Interferon-alpha (Interferon Alfa)IBA 12/2023 - 02/2008
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 09/2015
4	VaccinesIBA 12/2023 - 12/2016
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2009
4	SugarsIBA 06/2013 - 04/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2013
3	Interferon Type IIBA 01/2022 - 01/2012
3	sodium-bile acid cotransporterIBA 12/2021 - 10/2017
3	Surface Antigens (Surface Antigen)IBA 01/2021 - 01/2017
3	Membrane Proteins (Integral Membrane Proteins)IBA 12/2019 - 08/2010
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2019 - 10/2017
2	pgRNAIBA 12/2022 - 01/2016
2	Viral AntigensIBA 12/2021 - 01/2017
2	Viral ProteinsIBA 12/2021 - 10/2019
2	AntibodiesIBA 12/2021 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 09/2010
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2019 - 01/2016
2	ureido-N-hexyl deoxynojirimycinIBA 01/2018 - 02/2017
2	glucosidase IIBA 01/2018 - 01/2015
2	Tetracycline (Achromycin)FDA LinkGeneric 10/2017 - 09/2013
2	ProdrugsIBA 02/2017 - 09/2013
2	Imino SugarsIBA 06/2013 - 01/2011
1	Therapeutic UsesIBA 01/2022
1	Viral RNAIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 12/2021
1	Capsid Proteins (Capsid Protein)IBA 10/2020
1	AntigensIBA 01/2020
1	platelet protein P47 (pleckstrin)IBA 01/2020
1	Protein SIBA 01/2020
1	STAT1 Transcription FactorIBA 01/2020
1	EnzymesIBA 01/2019
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	AphidicolinIBA 01/2019
1	Viral Envelope ProteinsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2018
1	2',3'-dideoxyguanosineIBA 12/2018
1	LuciferasesIBA 11/2017
1	Firefly LuciferasesIBA 11/2017
1	Janus KinasesIBA 10/2017
1	Circular DNAIBA 10/2017
1	LigandsIBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	benzamideIBA 01/2017
1	BenzodiazepinesIBA 12/2016
1	Ribonuclease H (RNase H)IBA 01/2016
1	Nucleic Acid Synthesis InhibitorsIBA 01/2016
1	ChemokinesIBA 02/2015
1	vadimezanIBA 02/2015
1	Toll-Like Receptor AgonistsIBA 02/2015
1	FluorineIBA 06/2013
1	AmidesIBA 04/2013
1	N-dodecyl-L-lysine amideIBA 04/2013
1	6H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA 02/2012
1	Ribavirin (Virazole)FDA LinkGeneric 01/2011

Therapy/Procedure

17	Therapeutics 12/2023 - 02/2008
2	Immunotherapy 10/2017 - 01/2017
2	Oral Administration 12/2016 - 01/2011